Sentence examples for block trail from inspiring English sources

Complementation of TAK1 in TAK1−/− MEFs effectively protected against TRAIL killing, whereas expression of TAK1-K63W failed to block TRAIL induced death as measured by PI exclusion (Fig. 1D) and MTT cell viability assay (Fig. S1).

However, only expression of FlipL, and not the other Flip forms, was able to efficiently block TRAIL killing in TAK1 knock out MEFs.

However, type I IFNs-neutralizing antibodies did not completely block TRAIL upregulation in HIV-1-infected culture (Fig. 6D, E), suggesting the involvement of a type I IFNs-independent pathway in the induction of TRAIL.

Despite the fact that TRAIL-R1, TRAIL-R2 and TRAIL-R4 induced NF-kB activation has been shown to be primarily mediated by TRAF2-NIK-IkappaB kinase alpha/beta signaling cascade [ 35], there is some doubt on whether or not NF-kB activation can block TRAIL mediated apoptosis.

Since both our RNAi-mediated knockdown methods achieved about 60% knockdown of OPG expression, possibly sufficient OPG remained to interact with and block TRAIL-induced apoptosis.

The data obtained in this experiment clearly showed that in both cell lines, NSA was able to completely block TRAIL-induced necroptosis sensitized with HHT or CHX.

TRAIL-R3 and TRAIL-R4, the two decoy receptors unable to transduce the death signal, are thought to block TRAIL-induced apoptosis by competing with TRAIL-R1 and TRAIL-R2 for the ligand (Ashkenazi and Dixit, 1999; Özören and El-Deiry, 2003).

In our experiments, Nec-1s wableble to completely block TRAIL-induced necroptosis (but had no effect on apoptosis; P for Mz-ChA-1 cells was 0.045 and thus only marginally below the significance threshold of 0.05) either sensitized by HHT or CHX, clearly confirming the relevance of RIPK1 in HHT- or CHX-enhanced TRAIL-induced necroptosis.

For example, somatic mutations in DR5 cause a dominant negative phenotype that blocks TRAIL signaling through DR4 and DR5, but has no effect on Fas signaling [19].

In NOD mice, blocking TRAIL function by a soluble TRAIL receptor increased the onset of diabetes.

As TRAIL is increased with obesity, we wonder whether blocking TRAIL signaling would also prevent the development of insulin resistance.